The Valley Desk

ArticleAlimentary pharmacology & therapeuticsPublished

Impacts of glucagon-like peptide-1 receptor agonists on the risk of adverse liver outcomes in patients with metabolic dysfunction-associated steatotic liver disease cirrhosis and type 2 diabetes

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Alimentary pharmacology & therapeutics
Published
Subject terms
Humans; Carcinoma, Hepatocellular; Liver Neoplasms; Fatty Liver; Hypertension, Portal; Liver Cirrhosis; Metabolic Diseases; Diabetes Mellitus, Type 2; Hypoglycemic Agents; Retrospective Studies; Glucagon-Like Peptide-1 Receptor Agonists; Hepatic Decompensation
PubMed ID
38538967
Added to directory
Source checked

Report a correction or request removal